Impact BioMedical Inc. (IBO)
NYSE: IBOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
IBO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $38.28M
- P/E (TTM)
- 0.40
- EPS (TTM)
- $11.11
- Dividend yield
- None
- 52-week range
- 4.36 – 10.51
- Day range
- 4.36 – 4.59
- Volume / Avg
- 10.73K / 11.49K
- Beta
- —
- Shares outstanding
- 8.54M
- Next earnings
- Nov 6, 2026
52-week range
IBO stock today
On Oct 7, IBO ended the session at $4.48, shedding $0.20 (4.27%), versus the S&P 500's 0.22% decline. At this level, IBO sits near the bottom of its 52-week range of $4.36 to $10.51: 57.4% below the high, set on Mar 5, 2026 and 2.8% above the low. IBO is down 29.9% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 42.7%.
Impact BioMedical trades at 0.4x its trailing twelve-month earnings per share of $11.11. Impact BioMedical's next earnings report is expected on Nov 6, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Impact BioMedical
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2024
Earnings
Earnings history- Next report
- Nov 6, 2026
Impact BioMedical peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| LITSLite Strategy Inc. | 1.27 | -9.93% | $38.62M | vs IBO |
| FLNAFilana Therapeutics Inc. | 0.8157 | -6.77% | $39.40M | vs IBO |
| NNVCNanoViricides Inc. | 1.44 | +2.86% | $36.76M | vs IBO |
| IXHLIncannex Healthcare Inc. | 3.18 | +1.27% | $39.89M | vs IBO |
| CPHIChina Pharma Holdings Inc. | 0.85 | +32.58% | $36.57M | vs IBO |
| BCTXBriaCell Therapeutics Corp. | 4.00 | -0.50% | $34.80M | vs IBO |
| VERUVeru Inc. | 2.46 | -0.40% | $41.94M | vs IBO |
| ATNMActinium Pharmaceuticals Inc. (Delaware) | 1.07 | -3.60% | $33.64M | vs IBO |
Indexes, lists and sector
Impact BioMedical stock FAQ
What is Impact BioMedical's stock price today?
IBO last traded at $4.48 as of Oct 7, 4:00 PM EDT, down 4.27% on the day. Prices are delayed at least 15 minutes.
Does Impact BioMedical pay a dividend?
No. Impact BioMedical does not currently pay a regular cash dividend.
When is Impact BioMedical's next earnings date?
Impact BioMedical is expected to report earnings on Friday, November 6, 2026.
What is IBO's P/E ratio?
IBO trades at a trailing P/E ratio of 0.40.
Has IBO ever split its stock?
Yes. The most recent IBO stock split was a 79-for-1000 split on Sep 23, 2026.
What is the IBO 52-week high?
The 52-week high for IBO is $10.51 and the 52-week low is $4.36. The stock is currently 57.4% below its high.